SPECTRAPHASE

spectraphase-logo

SpectraPhase proposes to develop, patent and commercialize technology for a blood glucose monitor that takes continuous readings on a real-time basis. With superior diagnostic data, hospital ICU staff can properly manage patients' blood sugar levels and expect both better patient outcomes and significant cost reductions for ICU administrators. SpectraPhase is led by CEO Chris Condit, a graduate student at UT, and founding member of CardioSpectra, an Austin-based medical diagnostics startup that successfully sold for $63M in 2007.

#Financial #More

SPECTRAPHASE

Industry:
Developer Platform Health Care Information Services Information Technology

Address:
Austin, Texas, United States

Country:
United States

Total Employee:
1+

Status:
Active

Total Funding:
0


Investors List

texas-venture-labs_image

Texas Venture Labs

Texas Venture Labs investment in Non Equity Assistance - SpectraPhase

More informations about "SpectraPhase" on Search Engine